Oligosaccharide moieties on glycoproteins participate in intercellular communication, cell differentiation, and proliferation, and cellular transformation is accompanied by changes in cell surface glycoproteins. However, little is known about the structural and functional relationship of the oligosaccharyl chains and the regulation of their expression. Among the sugars that comprise the carbohydrate side chains, the participation of sialic acid, present only as terminal sugars in glycoproteins, is perhaps the most extensively, albeit incompletely, studied. While at least five, and most likely more, sialyltransferases are required in the biosynthesis of the major sialic acid linkages found in mammalian glycoproteins, four have been purified to homogeneity and characterized enzymatically. There are no data on their primary sequences, gene structures, or genomic organization. Furthermore, regulation of expression of the individual transferases, and functional differences of the products of the individual transferase reactions remain completely unexplored. In the long range, this research is directed at the elucidation of the regulatory pathways that dictate the expression of the individual sialyltransferases and their catalytic end-products. Toward this goal, a detailed molecular analysis of the sialyltransferases is proposed. First, sialyltransferase mRNAs will be studied by the isolation of recombinant clones from cDNA libraries. Second, sialyltransferase genomic sequences will be isolated. Comparative analysis of genomic and cDNA sequences will be performed to gain an in-depth understanding of the sialyltransferase family. Third, using probes that can distinguish between different sialyltransferase gene products, the regulated expression of the sialyltransferases in differentiating F-9 cells and in tissues of whole animals will be examined.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM038193-01
Application #
3294335
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1987-04-01
Project End
1990-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Appenheimer, Michelle M; Huang, Ruea-Yea; Chandrasekaran, E V et al. (2003) Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology 13:591-600
Wuensch, S A; Huang, R Y; Ewing, J et al. (2000) Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms. Glycobiology 10:67-75
Dimitroff, C J; Pera, P; Dall'Olio, F et al. (1999) Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 256:631-6
Dall'Olio, F; Chiricolo, M; Lau, J T (1999) Differential expression of the hepatic transcript of beta-galactoside alpha2,6-sialyltransferase in human colon cancer cell lines. Int J Cancer 81:243-7
Lo, N W; Dennis, J W; Lau, J T (1999) Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA. Biochem Biophys Res Commun 264:619-21
Dalziel, M; Lemaire, S; Ewing, J et al. (1999) Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology 9:1003-8
Lo, N W; Lau, J T (1999) Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence. Glycobiology 9:907-14
Kalcheva, I; Elliott, R W; Dalziel, M et al. (1997) The gene encoding beta-galactoside alpha2,6-sialyltransferase maps to mouse chromosome 16. Mamm Genome 8:619-20
Hu, Y P; Dalziel, M; Lau, J T (1997) Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region. Glycoconj J 14:407-11
Dall'Olio, F; Mariani, E; Tarozzi, A et al. (1997) Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis. Glycobiology 7:507-13

Showing the most recent 10 out of 24 publications